Peong Gang Park, Juhyeon Hwang, Yongjun Kim, Minki Hong, Donghwan Yun, Haein Yoon, Chaelin Kang, Sohyun Bae, Soo Heon Kwak, Yong Chul Kim, Kyung Chul Moon, Dong-Sup Lee, Yon Su Kim, Hee Gyung Kang, Hyun Je Kim, Seung Seok Han
Diabetes Metab J. 2025;49(5):1024-1039. Published online March 31, 2025
Background Due to the limited availability of therapeutic agents for type 2 diabetic kidney disease (T2DKD), there is a need for further knowledge derived from experimental models and innovative techniques. In addressing this issue, single-cell RNA sequencing (scRNA-seq) has been exclusively applied to a genetically modified diabetic kidney disease model, but not to an induced model representing T2DKD. Herein, we analyzed scRNA-seq and other experiments from an induced T2DKD model and validated the results in human-derived biospecimens.
Methods The model was induced by combining a high-fat diet with streptozotocin to simulate induced T2DKD. scRNA-seq, histological, and flow cytometric analyses were conducted, and the results were compared with control mice. The findings were then applied to human T2DKD kidneys.
Results Biochemical and histological analyses unveiled early-stage T2DKD features, such as hyperfiltration, increased proteinuria, glomerulomegaly, and interstitial fibrosis. scRNA-seq identified that proximal tubules secreted a variety of chemokines, potentially in response to crosstalk with glomeruli. Notably, C-X-C motif chemokine 12 (CXCL12) emerged as a key player in potentially promoting T-cell recruitment. Flow cytometry substantiated T-cell infiltration into the kidney of the T2DKD model. This finding was further corroborated in human biopsied kidney tissues, showing a correlation between elevated CXCL12 levels and T2DKD progression.
Conclusion The induced T2DKD model highlights the pivotal role of CXCL12-mediated T-cell infiltration, stemming from the crosstalk between proximal tubules and glomeruli. This data serves as a foundation for future studies, promising a therapeutic target for T2DKD.
Citations
Citations to this article as recorded by
Inflammation and Diabetic Kidney Disease Rong Mei Zhang, Maria Luiza Caramori International Journal of Molecular Sciences.2026; 27(2): 1097. CrossRef
Research progress in single‑cell omics technologies for kidney disease (Review) Jia Xu, Ziwei Chen, Shengyao Li, Xiaoya Wang, Ming Chen International Journal of Molecular Medicine.2026; 57(5): 1. CrossRef
SFRP2 aggravates diabetic kidney disease by repressing the renal protective CH25H/25-hydroxycholesterol axis in mesangial cells Dan Lv, Ziyue Lin, Jiakun Yang, Wuchao Li, Keqian Wu, Rui Peng, Handeng Liu, He Zha, Xiong Zhong Ruan, Xiaohui Liao, Yan Sun, Zheng Zhang Journal of Advanced Research.2026;[Epub] CrossRef
Qiling Hushen Formula Ameliorates Type 2 Diabetic Kidney Disease via Gut‐Kidney Axis Restoration and TLR4/NF‐κB/NLRP3 Suppression Yuxin Wang, Pei Sheng, Xue Wang, Min Lin, Wentao Cai, Shiyao Wei, Yuyun Du, Ming Yan, Lei Wang, Xiaofei An, Haoqiang Zhang Journal of Diabetes Research.2026;[Epub] CrossRef
Efficacy and safety of jinlida granule in the treatment of diabetic kidney disease: a systematic review and meta-analysis of randomized controlled trials Qi Yong, Yunxi Xu, Peiying Zhang, Hua Bai, Chao Xu, Hejiang Ye Frontiers in Pharmacology.2026;[Epub] CrossRef
Glomerulo–Tubular Crosstalk in Diabetic Kidney Disease: From Pathophysiology to Novel Therapeutics Il Young Kim Electrolytes & Blood Pressure.2026; 24(2): 106. CrossRef
Aging Mediates Inflammatory Transformation of Kidney-Resident Macrophages via Thrombospondin-1 Signaling Chaelin Kang, Donghwan Yun, Boyoun Jang, Yongjun Kim, Minki Hong, Juhyeon Hwang, Haein Yoon, Jeongmin Oh, Hyun Mu Shin, Kyung Chul Moon, Dong-Sup Lee, Yon Su Kim, Hyun Je Kim, Seung Seok Han Immune Network.2025;[Epub] CrossRef